Home | Recruitment

Recruiting

Trials by recruitment status

Public Title Date of registrationsort icon Sponsor
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed 2010-12-27 CIGB
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. 2010-12-28 CIM
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. 2010-12-29 CIM
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. 2010-12-29 CIM
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. 2010-12-29 CIM
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IV 2011-04-18 CENSA
TS-FARMEV Study 2011-05-16 CIGB
HeberproGen Study 2011-05-20 CIGB
MAGINC Study 2011-07-12 CIGB
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis. 2011-11-11 CIMAB
Therapeutic clinical evaluation of the Plectranthus amboinicus Lour Spreng (Oregano French) tablets in patient with common cold 2011-11-22 CIDEM
Nimotuzumab in tumors of head and neck .Phase IV 2013-02-01 CIMAB
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers 2013-02-08 CIGB
Pneumococcal conjugate vaccination among Warao children 2013-06-14 SAIB
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study 21/12/2020 BIOCEN
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. 22/04/2014 CNCMA
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study 22/05/2020 FINLAY
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 22/05/2020 FINLAY
VIDA study 22/06/2020 CIGB
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) 22/08/2013 CIGB